摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2S,4aS,7aR,12aR,14R)-5-(cyclopropylmethyl)-9-hydroxy-2,3,4,4a,5,6,7,12-octahydro-1H-2,7a-ethanoindeno[1,2-d]quinolin-14-yl]-N-methyl-2-phenylacetamide

中文名称
——
中文别名
——
英文名称
N-[(2S,4aS,7aR,12aR,14R)-5-(cyclopropylmethyl)-9-hydroxy-2,3,4,4a,5,6,7,12-octahydro-1H-2,7a-ethanoindeno[1,2-d]quinolin-14-yl]-N-methyl-2-phenylacetamide
英文别名
N-[(1R,9R,11R,14S,19R)-15-(cyclopropylmethyl)-4-hydroxy-15-azapentacyclo[9.6.2.01,9.02,7.09,14]nonadeca-2(7),3,5-trien-19-yl]-N-methyl-2-phenylacetamide
N-[(2S,4aS,7aR,12aR,14R)-5-(cyclopropylmethyl)-9-hydroxy-2,3,4,4a,5,6,7,12-octahydro-1H-2,7a-ethanoindeno[1,2-d]quinolin-14-yl]-N-methyl-2-phenylacetamide化学式
CAS
——
化学式
C31H38N2O2
mdl
——
分子量
470.655
InChiKey
CLPXFKZSJJMNEE-CHICSTKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    35
  • 可旋转键数:
    5
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    43.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    (2S,4aS,7aR,12aR)-5-(cyclopropylmethyl)-9-methoxy-2,4a,5,6,7,12-hexahydro-1H-2,7a-ethanoindeno[1,2-d]quinolin-14-one 在 palladium 10% on activated carbon 、 氢气吡啶盐酸盐 、 sodium cyanoborohydride 、 三乙胺 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 39.5h, 生成 N-[(2S,4aS,7aR,12aR,14R)-5-(cyclopropylmethyl)-9-hydroxy-2,3,4,4a,5,6,7,12-octahydro-1H-2,7a-ethanoindeno[1,2-d]quinolin-14-yl]-N-methyl-2-phenylacetamide
    参考文献:
    名称:
    Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain
    摘要:
    We designed and synthesized pentacyclic propellane derivatives with a 6-amide side chain to afford compounds with higher MOR/KOR ratio and lower sedative effects than nalfurafine. The obtained etheno-bridged derivative with a beta-amide side chain, YNT-854, showed a higher MOR/KOR ratio than nalfurafine. YNT-854 also exhibited a higher dose ratio between the sedative effect and the analgesic effect than observed with nalfurafine, which may guide the future design of useful analgesics with a weaker sedative effect than nalfurafine. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2015.08.036
点击查看最新优质反应信息

文献信息

  • Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain
    作者:Ryo Nakajima、Naoshi Yamamoto、Shigeto Hirayama、Takashi Iwai、Akiyoshi Saitoh、Yasuyuki Nagumo、Hideaki Fujii、Hiroshi Nagase
    DOI:10.1016/j.bmc.2015.08.036
    日期:2015.10
    We designed and synthesized pentacyclic propellane derivatives with a 6-amide side chain to afford compounds with higher MOR/KOR ratio and lower sedative effects than nalfurafine. The obtained etheno-bridged derivative with a beta-amide side chain, YNT-854, showed a higher MOR/KOR ratio than nalfurafine. YNT-854 also exhibited a higher dose ratio between the sedative effect and the analgesic effect than observed with nalfurafine, which may guide the future design of useful analgesics with a weaker sedative effect than nalfurafine. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 黎芦碱 鳥胺酸 魏因勒卜链接剂 雷迪帕韦二丙酮合物 雷迪帕韦 雷尼托林 锰(2+)二{[乙酰基(9H-芴-2-基)氨基]氧烷负离子} 达托霉素杂质 赖氨酸杂质4 螺[环戊烷-1,9'-芴] 螺[环庚烷-1,9'-芴] 螺[环己烷-1,9'-芴] 螺-(金刚烷-2,9'-芴) 藜芦托素 荧蒽 反式-2,3-二氢二醇 草甘膦-FMOC 英地卡胺 苯芴醇杂质A 苯并[a]芴酮 苯基芴胺 苯(甲)醛,9H-芴-9-亚基腙 芴甲氧羰酰胺 芴甲氧羰酰基高苯丙氨酸 芴甲氧羰酰基肌氨酸 芴甲氧羰酰基环己基甘氨酸 芴甲氧羰酰基正亮氨酸 芴甲氧羰酰基D-环己基甘氨酸 芴甲氧羰酰基D-Β环己基丙氨酸 芴甲氧羰酰基-O-三苯甲基丝氨酸 芴甲氧羰酰基-D-正亮氨酸 芴甲氧羰酰基-6-氨基己酸 芴甲氧羰基-高丝氨酸内酯 芴甲氧羰基-缬氨酸-1-13C 芴甲氧羰基-beta-赖氨酰酸(叔丁氧羰基) 芴甲氧羰基-S-叔丁基-L-半胱氨酸五氟苯基脂 芴甲氧羰基-S-乙酰氨甲基-L-半胱氨酸 芴甲氧羰基-PEG9-羧酸 芴甲氧羰基-PEG8-琥珀酰亚胺酯 芴甲氧羰基-PEG7-羧酸 芴甲氧羰基-PEG4-羧酸 芴甲氧羰基-O-苄基-L-苏氨酸 芴甲氧羰基-O-叔丁酯-L-苏氨酸五氟苯酚酯 芴甲氧羰基-O-叔丁基-D-苏氨酸 芴甲氧羰基-N6-三甲基硅乙氧羰酰基-L-赖氨酸 芴甲氧羰基-L-苏氨酸 芴甲氧羰基-L-脯氨酸五氟苯酯 芴甲氧羰基-L-半胱氨酸 芴甲氧羰基-L-β-高亮氨酸